Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Messing

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Urology|March 26, 2013
Higher expression of peroxisome proliferator-activated receptor γ or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasionDong-Rong Yang, Shin-Jen Lin, Xian-Fan Ding, et al.
Clinical Interventions in Aging|June 20, 2015
Bladder cancer in the elderly patient: challenges and solutionsElizabeth A Guancial, Breton Roussel, Derek P Bergsma, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Is there a favorable subset of patients with prostate cancer who develop oligometastases?Deepinder Singh, Won Sam Yi, Ralph A Brasacchio, et al.
Nature Reviews. Urology|April 18, 2023
The androgen receptor in bladder cancerJinbo Chen, Chi-Ping Huang, Chao Quan, et al.
Molecular Cancer Therapeutics|August 13, 2015
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer ProgressionZhiqun Shang, Yanjun Li, Minghao Zhang, et al.
Oncogene|September 12, 2019
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signalingJinbo Chen, Fuju Chou, Shuyuan Yeh, et al.
Medical Physics|September 13, 2006
Vivo motion and force measurement of surgical needle intervention during prostate brachytherapyTarun Podder, Douglas Clark, Jason Sherman, et al.
Brachytherapy|March 2, 2005
Bouquet brachytherapy: feasibility and optimization of conically spaced implantsLei Fu, Wan Sing Ng, Haisong Liu, et al.
The Journal of Urology|October 22, 2008
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794Gregory P Swanson, Bryan Goldman, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794Gregory P Swanson, Michael A Hussey, Catherine M Tangen, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Urology|March 26, 2013
Higher expression of peroxisome proliferator-activated receptor γ or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasionDong-Rong Yang, Shin-Jen Lin, Xian-Fan Ding, et al.
Clinical Interventions in Aging|June 20, 2015
Bladder cancer in the elderly patient: challenges and solutionsElizabeth A Guancial, Breton Roussel, Derek P Bergsma, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Is there a favorable subset of patients with prostate cancer who develop oligometastases?Deepinder Singh, Won Sam Yi, Ralph A Brasacchio, et al.
Nature Reviews. Urology|April 18, 2023
The androgen receptor in bladder cancerJinbo Chen, Chi-Ping Huang, Chao Quan, et al.
Molecular Cancer Therapeutics|August 13, 2015
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer ProgressionZhiqun Shang, Yanjun Li, Minghao Zhang, et al.
Oncogene|September 12, 2019
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signalingJinbo Chen, Fuju Chou, Shuyuan Yeh, et al.
Medical Physics|September 13, 2006
Vivo motion and force measurement of surgical needle intervention during prostate brachytherapyTarun Podder, Douglas Clark, Jason Sherman, et al.
Brachytherapy|March 2, 2005
Bouquet brachytherapy: feasibility and optimization of conically spaced implantsLei Fu, Wan Sing Ng, Haisong Liu, et al.
The Journal of Urology|October 22, 2008
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794Gregory P Swanson, Bryan Goldman, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794Gregory P Swanson, Michael A Hussey, Catherine M Tangen, et al.
Pageof 8